Dow Up 1.30% Nasdaq Up 0.37%

AVEO Pharmaceuticals, Inc. (AVEO)

-NasdaqGS
1.00 0.02(1.99%) Oct 30, 4:00PM EDT
Prev Close:0.98
Open:0.98
Bid:0.51 x 3900
Ask:1.35 x 3000
1y Target Est:1.67
Beta:0.88
Next Earnings Date:N/A
Day's Range:0.97 - 1.03
52wk Range:0.85 - 2.20
Volume:52,770
Avg Vol (3m):332,294
Market Cap:51.77M
P/E (ttm):N/A
EPS (ttm):-1.27
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

» More Headlines for AVEO

Comparison

Symbol% ChgMkt Cap
AVEOUp 1.99%51.77M
AMGN122.96B
PFE189.21B
RHHBY252.63B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):2.85
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-0.92
Quarterly EPS Est (Sep-14) :-0.23
Mean Recommendation*:3.5
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

AVEO Pharmaceuticals, Inc., doing business as AVEO Oncology, a biopharmaceutical company, is engaged in discovering, developing, and commercializing targeted cancer therapies using its Human Response Platform. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback